These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16098147)
21. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling. Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360 [TBL] [Abstract][Full Text] [Related]
22. Repression of SOX6 transcriptional activity by SUMO modification. Fernández-Lloris R; Osses N; Jaffray E; Shen LN; Vaughan OA; Girwood D; Bartrons R; Rosa JL; Hay RT; Ventura F FEBS Lett; 2006 Feb; 580(5):1215-21. PubMed ID: 16442531 [TBL] [Abstract][Full Text] [Related]
23. Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway. Huet G; Mérot Y; Percevault F; Tiffoche C; Arnal JF; Boujrad N; Pakdel F; Métivier R; Flouriot G J Biol Chem; 2009 Dec; 284(49):33729-39. PubMed ID: 19826002 [TBL] [Abstract][Full Text] [Related]
24. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. Selvaraj A; Prywes R J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952 [TBL] [Abstract][Full Text] [Related]
25. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Muehlich S; Wang R; Lee SM; Lewis TC; Dai C; Prywes R Mol Cell Biol; 2008 Oct; 28(20):6302-13. PubMed ID: 18694962 [TBL] [Abstract][Full Text] [Related]
26. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668 [TBL] [Abstract][Full Text] [Related]
27. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration. Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816 [TBL] [Abstract][Full Text] [Related]
29. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Schmidt D; Müller S Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732 [TBL] [Abstract][Full Text] [Related]
30. Sumoylated SnoN represses transcription in a promoter-specific manner. Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324 [TBL] [Abstract][Full Text] [Related]
31. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor. Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004 [TBL] [Abstract][Full Text] [Related]
33. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. Subramanian L; Benson MD; Iñiguez-Lluhí JA J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558 [TBL] [Abstract][Full Text] [Related]
34. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. Cen B; Selvaraj A; Prywes R J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164 [TBL] [Abstract][Full Text] [Related]
35. Sumoylation of a meiosis-specific RecA homolog, Lim15/Dmc1, via interaction with the small ubiquitin-related modifier (SUMO)-conjugating enzyme Ubc9. Koshiyama A; Hamada FN; Namekawa SH; Iwabata K; Sugawara H; Sakamoto A; Ishizaki T; Sakaguchi K FEBS J; 2006 Sep; 273(17):4003-12. PubMed ID: 16879611 [TBL] [Abstract][Full Text] [Related]
37. SUMOylation modulates transcriptional repression by TRPS1. Kaiser FJ; Lüdecke HJ; Weger S Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059 [TBL] [Abstract][Full Text] [Related]
38. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation. Guo Y; Yang MC; Weissler JC; Yang YS Biochem Biophys Res Commun; 2008 Sep; 374(3):570-5. PubMed ID: 18655774 [TBL] [Abstract][Full Text] [Related]
39. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation. Yan J; Yang XP; Kim YS; Joo JH; Jetten AM Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038 [TBL] [Abstract][Full Text] [Related]
40. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO. Yunus AA; Lima CD Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]